Chronic kidney disease. Best practice management Dr Fiona Mackie 2016
|
|
- Lee Cannon
- 5 years ago
- Views:
Transcription
1 Chronic kidney disease Best practice management Dr Fiona Mackie 2016
2 Strategies to delay progression of disease Management of chronic kidney disease Anaemia Nutrition/fluids Growth failure Calcium/phosphate balance
3 When the horse has bolted
4 Anaemia Prevalence data- children/adolescents with CKD (Wong H KI 2006) CKD Stage % Prevalence % Hb <12 mg/dl or treatment for anaemia Current definitions (KDIGO 2012) Age Hb g/dl (g/l) 6 mo-5 yrs 11.0 (110) 5-12 yrs 11.5 (115) yrs 12 (120) Non pregnant females >15 yrs 12 (120) Males >15 13 (130)
5 Causes of anaemia Multifactorial: Erythropoetin deficiency, lack of iron availability, inflammation, blood loss, hyperparathyroidism, B12 and folate deficiency Usually lower O2 availability induces EPO production. As GFR, decreases there is a decrease in fractional Na reabsorption, therefore a decrease in oxygen use and therefore a decrease in EPO production
6 Impact of anaemia in children Decreased Hb levels are independently associated with the development of LVH in children with CKD ( Mitsnefes JASN 2010) 52% increase in mortality risk in patients with hematocrit <33% at dialysis institution- NAPRTCS Warady et al Ped Neph 2003 IPPN: increase in patient mortality of 5 vs 2% at 12 mths, 8 vs 4% at 24 mths with Hb <11g/dL (JASN 2013) Increased rate of hospitalisations Poorer school performance
7 Treatment of anaemia- iron deficiency; absolute and functional How often should we measure?: KDIGO recommends measuring transferrin saturation (TSAT) and ferritin every 3 mths or more often if starting or adjusting ESA s What should we measure?: KDIGO recommends Transferrin- indicator of total iron binding capacity but has diurnal variation and is nutritionally dependent Serum ferritin- stored iron; but also an acute phase reactant Most acceptable in children- TSAT ( serum iron/total iron binding capacity x 100. Is derived from transferrin level x 1.4. Best predictor of iron deficiency TSAT <20%
8 How should we treat iron deficiency? Iron target: KDIGO 2012 target saturation >20% and ferritin >100 ng/ml. Use oral iron first unless on HD- then use IV iron (trial data suggests more effective in children on HD) IV iron formulations- can have anaphylaxis (more common with iron dextran). Must be monitored appropriately with resuscitation facilities available. Problem if IV tissues (tattoo)
9 Treating iron deficiency KDIGO 2012 recommendations for children (RCT evidence) If on HD: ferric gluconate 1.5 mg/kg weekly for 8 doses if iron deficient If on HD and iron replete 1 mg/kg/week and adjust according to iron studies If using oral iron- dose recommended for treatment in children is 2-6 mg/kg/day (elemental) in 2 divided doses
10 Sometimes oral iron is not successful in PD or CKD patients Sydney Children s Hospital protocol for iron polymaltose Use pre-meds; monitor
11 Iron polymaltose dosing for HD patients
12 Erythropoietin analogues KDIGO targets Hb Available: T 1/2 Dose Dosing frequency Epoetin alfa 150 u/kg/wk 3 times per wkweekly Shorter half life Darbopoetin IV 25 h; sc 48 h 0.45 µg/kg weekly or 0.75µg/kg q 2 weeks 1-2 weeks Painful on injection Methoxy polyethylene glycolepoietin beta (Mircera) 135 hrs 1.2 mcg/kg monthly monthly Less painful; can be given monthly Infants and young children may require much higher dosesmuch higher than adults. HD patients require more than PD patients (greater blood losses) Dose modification no more frequently than every 2 weeks
13 ESA resistance Either from the start or it develops over time Possible causes iron deficiency inflammation (increased hepcidin levels limits GI absorption in gut and liver release) bone disease ACEI/ARB acidosis vitamin C or folate deficiency malnutrition antibody to ESA- pure red cell aplasia- rare and hard to diagnose
14 Fluids and nutrition
15 Management of chronic kidney disease- Fluids KDIGO 2013 recommendations: Supplemental free water and sodium supplements should be given to children with CKD and polyuria to avoid chronic intravascular depletion and promote growth (Level 1C evidence) If hypertension >95 pc then sodium should be restricted to age based sodium requirement levels Age Upper limit Na per day <1 yr No data KDIGO yrs 1500 mg
16 Protein energy wasting PEW ( malnutrition in CKD) Orexigenic hormones eg acyl grelin uremia Protein energy wasting Desacyl ghrelin, adinopectin, letpin anabolism GI losses eg vomiting from GOR; albumin losses on PD or nephrotic Inadequate caloric intake Altered taste
17 Risk factors for PEW Infants Reduced residual renal function; inadequate dialysis dose Metabolic acidosis Low birth weight, small for gestational age Psychosocial factors Co-morbidity- neurological disease, CVS PD losses (of amino acids and proteins)
18 Evaluation of nutrition in children with CKD Any unit looking after children with CKD should have access to a dietitian Why is it so important: For every 2 SDS above or below a BMI of 0.5 the risk of mortality increases by 26% in children ( u shape curve; Wong CS AM J KD ESKD children from USRDS data))
19 What to evaluate and how? 3 day diet records from family
20 Evaluation of nutrition npcr is calculated from the intradialytic increase in BUN between HD sessions. A low npcr predicts weight loss in adolescents on HD (evidence); recommended to measure monthly in adolescents on HD. Can use online calculators eg hsls.pitt.edu No good biochemical marker but albumin does correlate with mortality in children and adults so helps with severity
21 Management of nutrition- few detailed guidelines CARI (Australia) 2005 Ensure the energy intake is that of a healthy child of the 50 th percentile height of the same age to allow catch-up growth. If this can not be maintained orally, commence feeds nasogastric or gastrostomy Many studies have demonstrated improved growth especially in infants <2 yrs with MG/gastrostomy feeds in CKD (however not NAPRTCS study)
22 Nutrition guidelines The net glucose intake from PD is 8% energy requirements per day- take this into account if overweight (Salusky 1983) Gastrostomy tubes should not be inserted at the time of a PD dialysis catheter (either well before or after) because of peritonitis risk KDOQI recommends measuring water soluble vitamins, zinc and copper every 4 months in dialysis patients and supplementing (not adult doses)
23 Growth
24 Short stature Definition: height of 2 SD s below mean for age and sex (below the 2.5 percentile) Worse if infant onset of CKD ESPN Data: 45% of children starting dialysis < 19yrs had a final adult height <3 rd centile age/sex matched. However there have been improvements over the last 2 decades. Consequences: Increased mortality (complex includes influences of nutrition, bone disease etc); reduced QOL; poorer school performances and reduced income
25 Risk factors for poor linear growth Infant onset of CKD Low birth weight and small for gestational age Protein energy wasting Incompatible dialysate solutions Inadequate dialysis dose (daily HD better growth than conventional)
26 Growth hormone therapy GH stimulates linear growth, increases muscle mass and improves bone density Insensitivity to GH, reduced transcription of IGF1 Effect of supraphysiological doses of GH- does have a positive effect on final height. Better predialysis; effect decreases after 1 st year Metanalysis data: safe to use post transplant (no increased risk of rejection) Caution not to use in children with severe renal osteodystrophy- manage this first
27 CKD Mineral Bone Disorder CKD-MBD Simplified diagram showing muti-organ interactions in regulation of phosphate homoeostasis FGF23 produced in the bone cells can suppress renal NaPi-2a and NaPi-2c co-transporter activities to increase the urinary excretion of phosphate. Suppression of renal alpha hydroxylase by FGF23/Klotho leads to reduced 1,25 OH2D 2011 by Portland Press Ltd M. Shawkat Razzaque Clin. Sci. 2011;120:91-97
28 FGF23 elevation Independent risk factor for mortality in adults with CKD and general population Why is it elevated in CKD? Not fully understood possibly oral phosphate loading transient increases in PTH reduced Klotho iron deficiency stimulates FGF 23 transcription in osteocytes
29 Calcium based binders either have no effect or increase FGF 23 The appropriate therapy to minimise FGF23 rise and prevent CVS morbidity remains to be defined Salusky Ped Neph 2015
30 Current CK-MBD recommendations There are new guidelines to be released by KDIGO this year Existing recommendations for phosphate are to maintain no higher than age limits for CKD stages 1-4; lower targets for CKD stage 5 Initially dietary restriction even lower if raised PTH 0 to 0.5 years 100 mg/day 0.5 to 1 year 275 mg/day 1 to 3 years 460 mg/day 4 to 8 years 500 mg/day 9 to 19 years 1250 mg/day Phosphate binders- calcium containing vs non-calcium containing (sevelemar)
31 Problem of hypercalcemia Calcium absorption from phosphate binders is increased if taken between meals and also if taking active vitamin D as well
32 2 studies in children comparing sevelemar to calcium acetate. Equal reduction in phosphate, less hypercalcemia with sevelemar. Use both calcium and non-calcium containing binders to reduce cost.
33 Management of CK-BMD PTH goals: if elevated reduce phosphate and then if still elevated start calcitriol PTH targets are controversial IPPN- for children on PD target PTH times upper limit of normal Measure 25 hydroxyvitamin D and replace if low
34 How often to measure? For calcium and phosphorus measurements, the KDOQI guidelines recommend [1]: Stage 2 disease Measurements at least yearly Stage 3 disease Measurements at least every six months Stage 4 disease Measurements at least every three months Stage 5 disease Measurements at least monthly For PTH and alkaline phosphatase measurements, the KDOQI guidelines recommend: Stage 2 disease Measurements at least yearly Stage 3 disease Measurements at least every six months Stage 4 and 5 disease Measurements at least every three months Bone biopsy rarely indicated or done
35 Lipids Current KDIGO guidelines for adults- recommend statins for adults >50 with GFR <60 ml/min/1.73 m2 or post kidney transplant but not those on dialysis (lack of supporting trial data) We know the atherosclerotic process begins in childhood KDIGO recommends baseline measurement of lipids in children to exclude familial hypertriglyceridemia or rare inherited lipid disorders First line treatment: lifestyle modification/dietary? Fish oil for hypertriglyceridemia- 3 trials in pediatrics showing it reduces TG No recommendations for statins in children- lack of trial evidence and outcome data
36 Wingen AM et al Randomised multicentre study of a low protein diet on the progression of chronic renal failure in children Lancet 349: Hypertension Hypertension is an independent risk factor for progression of renal disease in children
37 ESCAPE trial 2009 Progression of Renal Disease, According to Blood-Pressure-Control Group Endpoint was >50 % decline in GFR or ESKD Intensive BP target below the 50 th percentile compared with conventional 50-95th pc resulted in significantly less reduction in GFR The ESCAPE Trial Group. N Engl J Med 2009;361:
38 Antihypertensives Ideally agents that target RAAS- added benefit of antiproteinuric ACE inhibitors- ESCAPE trial AT Receptor antagonists Combined ACEI andatra- minor additional effect on BP (4 mmhg) vs monotherapy but significantly increased anti-proteinuric effect 30%. Caution in adults (ONTARGET study high risk CVS disease adults no additional benefit in combination and more adverse events) Aldosterone inhibition- could help with aldosterone escape that occurs with chronic ACEI. Spironolactone not ideal as endocrine effects; can use eplerenone if available. Calcium channel blockers- no antiproteinuric effect- only use with ACEI/AT RA in early stages of CKD. May need to be used alone in more advanced CKD because of hyperkalemia Beta blockers- metoprolol in older studies equivalent antiproteinuric effect to ACEI.
39 Vaccination CKD children are at risk of more serious consequences of vaccine preventable infections (including Influenza) They should receive all standard immunisations- especially pretransplant Ensure Hep B levels remain adequate recommended >10 (measure annually). Require adult doses of Hep B vaccine Give influenza vaccine annually HPV (papilloma) virus vaccine important-as at long term increased risk (especially post transplant) of HPV related cancers. We recently demonstrated adequate initial response in immunosuppressed children (Vaccine 2016) Live vaccines should not routinely be given post transplant- there are a few published studies of use with varicella. Use only with extreme caution- should always try to vaccinate pre transplant
40
41 Overall management of the child with CKD Close attention to detail, regular follow up A multidisciplinary team that includes dietitians, nurses, social workers, psychologists Good patient and parent educationinformation about dialysis and benefits of living kidney donation
No Disclosures 03/20/2019. Learning Objectives. Renal Anemia: The Basics
Renal Anemia: The Basics Meredith Atkinson, M.D., M.H.S. Associate Professor of Pediatrics Johns Hopkins School of Medicine 16 March 2019 No Disclosures Learning Objectives At the end of this session the
More informationANEMIA & HEMODIALYSIS
ANEMIA & HEMODIALYSIS The anemia of CKD is, in most patients, normocytic and normochromic, and is due primarily to reduced production of erythropoietin by the kidney and to shortened red cell survival.
More informationChronic Kidney Disease
Chronic Kidney Disease Presence of kidney damage or decreased kidney function for three or more months, - necessary to distinguish CKD from acute kidney disease. Ascertained either by kidney biopsy or
More informationPediatric Nutrition and Kidney Disease
Pediatric Nutrition and Kidney Disease Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Objectives
More informationChronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Guideline (2010) Chronic Kidney Disease CKD: Executive Summary of Recommendations (2010) Executive Summary of Recommendations Below are the major recommendations
More informationCHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER. The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR
CHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR OUTLINE: A journey through CKD Screening for CKD: The why,
More informationManagement of anemia in CKD
Management of anemia in CKD Pierre Cochat, MD PhD Professor of Pediatrics Chair, Pediatrics & Pediatric Surgery Department Head, Center for Rare Renal Diseases Néphrogones Hospices Civils de Lyon & University
More informationPRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP
PRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP OUTLINE INTRODUCTION BURDEN OF CKD DEFINITION OF PRE-DIALYSIS CARE (PDC) GOALS OF PDC IN CKD COMPONENTS OF PDC ADVANTAGES
More informationTABLE OF CONTENTS T-1. A-1 Acronyms and Abbreviations. S-1 Stages of Chronic Kidney Disease (CKD)
A-1 Acronyms and Abbreviations TABLE OF CONTENTS S-1 Stages of Chronic Kidney Disease (CKD) Chapter 1: Nutrition Assessment Charts, Tables and Formulas 1-2 Practical Steps to Nutrition Assessment Adult
More informationIrish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012
Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE
More informationAssessment and monitoring of CKD stages 1-3
Assessment and monitoring of CKD stages 1-3 Annual Paediatric Nephrouroradiology and Network Symposium 2014 Pearl Pugh Paediatric Renal Dietitian Nottingham Children s Hospital Goals of Dietetic Management
More informationin CKD Patients Associate Professorr of Medicine Iran University of Medical Sciences
Management of Nutrition in CKD Patients Shokoufeh Sa avaj MD Associate Professorr of Medicine Iran University of Medical Sciences Introduction Dietary factors may have an effect on the progression of kidney
More informationRENAL ANAEMIA. South West Renal Training Scheme Cardiff October 2018
RENAL ANAEMIA South West Renal Training Scheme Cardiff October 2018 Dr Soma Meran Clinical Senior Lecturer and Honorary Consultant Nephrologist, University Hospital of Wales. Aims Biology of renal anaemia
More informationDisclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease
Disclosures Chronic Kidney Disease Consultant: Baxter Healthcare J. Kevin Tucker, M.D. Brigham and Women s Hospital Massachusetts General Hospital Topics Staging of chronic kidney disease (CKD) How to
More informationAnemia Management in Peritoneal Dialysis Patients Pranay Kathuria, FACP, FASN
Anemia Management in Peritoneal Dialysis Patients Pranay Kathuria, FACP, FASN Professor of Medicine Director, Division of Nephrology and Hypertension University of Oklahoma College of Medicine Definition
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationThanks to our Speaker!
Thanks to our Speaker! Poyyapakkam R. Srivaths, MD, MS Medical Director of Pheresis Services Pediatric Renal Section at Texas Children s Hospital Texas Children s Hospital - Houston, Texas Chronic Kidney
More informationNutrition Management of Children on Dialysis
Nutrition Management of Children on Dialysis Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Learning
More informationDo We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital
Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker
More informationSummary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup
http://www.kidney-international.org & 2012 KDIGO Summary of Recommendation Statements Kidney International Supplements (2012) 2, 283 287; doi:10.1038/kisup.2012.41 Chapter 1: Diagnosis and evaluation of
More informationMignon McCulloch. Associate Professor Paediatric Nephrology/Critical Care Red Cross Children s Hospital (RXH) University of Cape Town
Chronic Kidney Disease (CKD) Mignon McCulloch Associate Professor Paediatric Nephrology/Critical Care Red Cross Children s Hospital (RXH) University of Cape Town Chronic Renal Failure(CRF) = Chronic Kidney
More informationLaunch Meeting 3 rd April 2014, Lucas House, Birmingham
Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease Launch Meeting 3 rd April 2014, Lucas House, Birmingham Prof Sunil Bhandari
More informationMacro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center
Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and
More informationDietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components?
Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? 3 rd International Conference of European Renal Nutrition Working Group of ERA-EDTA
More informationOffice Management of Reduced GFR Practical advice for the management of CKD
Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE
More informationK atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006
K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006 Why new guidelines? Rationale for KDOQI Anemia 2006 Expand scope to all
More informationChronic Kidney Disease
Chronic Kidney Disease Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the Identification
More informationChronic Kidney Disease in Primary Care
Clinical Stream Chronic Kidney Disease in Primary Care Dr Gerald Waters Dr Gerald Waters Renal Physician Chronic Kidney Disease Chronic Kidney Disease Normal functions of Kidneys Management of CKD Drugs
More informationChronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines
More informationCKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College
CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)
More informationPersistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019
Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal
More informationApplying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
More informationLong-Term Care Updates
Long-Term Care Updates January 2016 By Yunuo (Enora) Wu, PharmD Chronic kidney disease (CKD) is defined as kidney damage (including structural or functional abnormalities) or glomerular filtration rate
More informationSUBJECT INDEX. Tvedegaard, E., 20. Ulerich, L., E1 (July) Wapensky, T., 45 Warner, J., 116 Warsaba, D., 52
268 Supasyndh, O., 134 Suraci, C., 208 Tatangelo, P., 208 Tavares, I., 157 Tozzo, C., 208 Tvedegaard, E., 20 Ulerich, L., E1 (July) Wapensky, T., 45 Warner, J., 116 Warsaba, D., 52 Wells, L.M., 26 Winkler,
More informationNational Institute for Health and Care Excellence
National Institute for Health and Care Excellence 2-year surveillance (2017) Chronic kidney disease: managing anaemia (2015) NICE guideline NG8 Appendix A3: Summary of new evidence from surveillance Diagnostic
More informationIpovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano
Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale Maurizio Gallieni Università degli Studi di Milano G Ital Nefrol 2018 - ISSN 1724-5990 Nutrients 2017, 9, 328 Vitamin D deficiency (
More informationMalnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationChronic kidney disease : The role of the Pharmacist
Chronic kidney disease : The role of the Pharmacist Dr. Alladin-Karan (MBBS) Kidney Foundation of Guyana (KFG) Caribbean Association of Pharmacists Annual Convention Guyana Marriott Hotel 13 th August
More informationRenal Failure Update in Treatment Part 1. DANIEL WALTON, DO, FACP,FACOI,FASN PARTNER, AKDHC, LLC PHOENIX AZ (602)
Renal Failure Update in Treatment Part 1 DANIEL WALTON, DO, FACP,FACOI,FASN PARTNER, AKDHC, LLC PHOENIX AZ (602) 263 5446 dwalton@akdhc.com DISCLOSURES NONE OFF LABEL USE POSSIBLY LEARNING OBJECTIVES USE
More informationESRD Mortality. Causes of CKD in Children. Causes of Late Graft Failure. 5-Year Allograft Survival. All-cause mortality rates, 2005, by age
North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Causes of CKD in Children Founded in 1992 78 participating centers in Canada & U.S. 16,339 CKD patients age 0 18 years 9,506 renal
More informationEfficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia. Ioannis Griveas, MD, PhD
Efficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia Ioannis Griveas, MD, PhD Anaemia is a state in which the quality and/or quantity of circulating red blood cells are below
More information8/22/1395 Dr. F. Moeinzadeh
1 How I treat CKD Dr. Firouzeh Moeinzadeh Táá áàtçà ÑÜÉyxááÉÜ Éy axñ{üéäézç \áyt{tç hç äxüá àç Éy `xw vtä fv xçvxá 2 Aim of this lesson How I diagnosis a CKD patient? How I follow a CKD patient? How I
More informationRENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University
RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University OBJECTIVES By the end of this lecture each student should be able to: Define acute & chronic kidney disease(ckd)
More informationCKD-MBD CKD mineral bone disorder
CKD Renal bone disease Dr Mike Stone University Hospital Llandough Affects 5 10 % of population Increasingly common Ageing, diabetes, undetected hypertension Associated with: Cardiovascular disease Premature
More informationABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour
ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour Dr Indranil Dasgupta Rationale No national practical
More information2017 KDIGO Guidelines Update
2017 KDIGO Guidelines Update Clinic for Hemodialysis Clinical Center University of Sarajevo 13 th Congress of the Balkan cities Association of Nephrology, Dialysis, and Artificial Organs Transplantation
More informationTO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT?
TO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT? Rana G. Rizk, PhD, MPH, LD Maastricht University, The Netherlands November, 2017 Learning objectives Review the evidence behind benefits and concerns
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationNATIONAL QUALITY FORUM Renal EM Submitted Measures
NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB
More informationPrimary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources
August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES
Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel
More informationCase #1. Current Management Strategies in Chronic Kidney Disease. Serum creatinine cont. Pitfalls of Serum Cr
Current Management Strategies in Chronic Kidney Disease Grace Lin, MD Assistant Professor of Medicine, University of California San Francisco Case #1 50 y.o. 70 kg man with long-standing hypertension is
More informationKidney damage with normal or increased GFR Kidney damage with mild reduction in GFR
CHRONIC KIDNEY DISEASE Contents Stages of Chronic Kidney Disease Dosing adjustments Hyperphosphataemia management Secondary hyperparathyroidism Anaemias Hyperkalaemia Acidosis Hypertension STAGES OF CHRONIC
More informationCONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL. Revised May 30, 2012
CONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL Douglas G. Kelling, Jr., MD C. Gismondi-Eagan, MD, FACP George C. Monroe III, MD Revised May 30, 2012 The information contained in this protocol
More informationAchieving Equilibrium in ESRD Patients
Achieving Equilibrium in ESRD Patients -Marc Richards MD -South Florida Kidney Disease and HTN Specialists -Chief of Medicine, BRRH -BRRH Grand Rounds: April 18 th, 2017 Outline Dialysis prescription Adequacy
More informationDIABETES AND YOUR KIDNEYS
DIABETES AND YOUR KIDNEYS OR AS WE CALL IT DIABETIC NEPHROPATHY The latest guidelines to keep you safe, healthy, fit, and out of danger from needing dialysis A UCLA HEALTH EDUCATIONAL SEMINAR Ramy M. Hanna
More informationHEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease
HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy
More informationFilters 1600 L of blood/day Makes 180 L of ultrafiltrate Kidney contains 600,000 to 1.4 million nephrons
Filters 1600 L of blood/day Makes 180 L of ultrafiltrate Kidney contains 600,000 to 1.4 million nephrons Filtered: Ammonia Protein Amino acids Creatinine Uric acid Electrolytes Some are then reabsorbed
More informationSecondary Hyperparathyroidism: Where are we now?
Secondary Hyperparathyroidism: Where are we now? Dylan M. Barth, Pharm.D. PGY-1 Pharmacy Resident Mayo Clinic 2017 MFMER slide-1 Objectives Identify risk factors for the development of complications caused
More informationHemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK
Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009
More informationLunch and Learn Fresno Veterinary Specialty and Emergency Center March 19, Domenico Bianco, DVM, PhD, DACVIM
Lunch and Learn Fresno Veterinary Specialty and Emergency Center March 19, 2013 Domenico Bianco, DVM, PhD, DACVIM Outline Diagnosis of chronic kidney disease (CKD) Acute kidney injury (AKI) vs. CKD International
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers STAGED
More informationKidney Disease. Chronic kidney disease (CKD) requiring dialysis. The F.P. s Role in the Management of Chronic. Stages
Focus on CME at McMaster University The F.P. s Role in the Management of Chronic Kidney Disease By David N. Churchill, MD, FRCPC, FACP Presented at McMaster University CME Half-Day in Nephrology for Family
More informationHEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI
HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI high-flux Hemodiafiltration (HDF) Combination of two dialysis techniques, hemodialysis and hemofiltration:
More informationStages of Chronic Kidney Disease (CKD)
Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR
More informationNutrition. Chapter 45. Reada Almashagba
Nutrition Chapter 45 1 Nutrition: - Nutrient are organic substances found in food and are required for body function - No one food provide all essential nutrient Major function of nutrition: providing
More informationADVANCES. Annual reports from the Centers for. In Anemia Management. Anemia Management in the United States: Is There Opportunity for Improvement?
ADVANCES Vol. 1 No.1 22 We are pleased to introduce our newest NPA publication, Advances in Anemia Management. This quarterly publication will address contemporary issues relating to the treatment of anemia
More informationTransforming Diabetes Care
Transforming Diabetes Care Diabetic Kidney Disease: Prevention, Detection and Treatment Alexis Chettiar, ACNP-BC, PhD(c) 1 Polling Question - 1 What is your role as a healthcare provider? a) Dietitian
More informationStages of chronic kidney disease
For mass reproduction, content licensing and permissions contact Dowden Health Media. Jonathan J. Taliercio, DO Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio talierj@ccf.org
More informationPrognosis in CKD Can we do anything about it? Rodney D Gilbert
Prognosis in CKD Can we do anything about it? Rodney D Gilbert A diagnosis of end stage renal failure implies what degree of loss of life expectancy? A. 10% B. 20% C. 30% D. 40% E. 50% F. 60% 38% 22% 16%
More informationPROs for Drug Development. Melanie Blank, MD
PROs for Drug Development in Chronic Kidney Disease Melanie Blank, MD Disclaimer The views expressed here represent my opinions and do not necessarily represent the views of the FDA. Overview Stagnation
More informationCa, Phos and Vitamin D Metabolism in Pre-Dialysis Patients
Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients A. WADGYMAR, MD Credit Valley Hospital, Mississauga, Ontario, Canada. June 1, 2007 1 Case: 22 y/o referred to Renal Clinic Case: A.M. 29 y/o Man
More informationEffective Health Care Program
Comparative Effectiveness Review Number 83 Effective Health Care Program Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease Executive Summary Background Chronic
More informationRenal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Mikhail et al. BMC Nephrology (2017) 18:345 DOI 10.1186/s12882-017-0688-1 CORRESPONDENCE Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease Ashraf Mikhail 1*, Christopher
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationFinal Case Study: Renal Disease Due 3/19/14 60 points
NUT 116BL Name: CHRISTINE WOO Winter 2014 Section: 1 Final Case Study: Renal Disease Due 3/19/14 60 points Part I: Initial Presentation Present Illness: Jenny is a 19 yo F student referred to the renal
More informationISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp
More informationEFFECTIVE SHARE CARE AGREEMENT
Specialist details Patient identifier Name: Tel: EFFECTIVE SHARE CARE AGREEMENT For the specialist use of Erythropoietin Stimulating Agent (ESA) Therapy (formerly known as EPO) for the correction of Anaemia
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More information02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis.
To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. Michael Shoemaker-Moyle, M.D. Assistant Professor of Clinical Medicine Objectives Review Vitamin D Physiology Review Current Replacement
More informationMaher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University
Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN
More informationJ.Bacchetta has documented that she has received grants for research activities from Amgen, Crinex, Sandoz.
J.Bacchetta has documented that she has received grants for research activities from Amgen, Crinex, Sandoz. Epidemiological, immune and metabolic aspects of vitamin D in CKD Justine Bacchetta, MD, PhD
More informationThe future is here. It s just not widely distributed yet. William Gibson
The future is here. It s just not widely distributed yet. William Gibson CHRONIC KIDNEY DISEASE MANAGEMENT A NEW PARADIGM Aaron Cass, MD, FRCPC Nephrologist, Fraser Health January 22, 2014 Where Are We
More informationchapter two clinical indicators and preventive care page
chapter two clinical indicators and preventive care If you believe in magic don t bother to choose If it s jug band music or rhythm and blues Just go and listen it ll start with a smile It won t wipe off
More informationManaging peri-operative anaemiathe Papworth way. Dr Andrew A Klein Royal Papworth Hospital Cambridge UK
Managing peri-operative anaemiathe Papworth way Dr Andrew A Klein Royal Papworth Hospital Cambridge UK Conflicts of interest: Unrestricted educational grants/honoraria from CSL Behring, Brightwake Ltd,
More informationThe real picture. Prorenin (Renin) PRR AT3 AT4. AT4 receptor. PAI 1 Abassi, Biochem Pharm, 2009
The real picture. Prorenin (Renin) PRR AT3-8 AT4 AT10-12 AT3 AT4 receptor PAI 1 Abassi, Biochem Pharm, 2009 Resistant Hypertension; Case based discussion Moving Targets? RAAS blockade in hypertensive CKD
More informationMetabolic Syndrome and Chronic Kidney Disease
Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationGUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE
GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if
More informationScottish Medicines Consortium
Scottish Medicines Consortium epoetin zeta, 1000 IU/0.3ml, 2000 IU/0.6ml, 3000 IU/0.9ml, 4000 IU/0.4ml, 5000 IU/0.5ml, 6000 IU/0.6ml, 8000 IU/0.8ml, 10,000 IU/1.0ml, 20,000 IU/0.5ml, 30,000 IU/0.75ml and
More informationCase Study: Renal Disease
Case Study: Renal Disease Laboratory Values: Lab Units Patient Normal Source Interpretation GFR ml/min 46 above 90 Renal Lecture 2 BUN mg/dl 40 10-20 NTP A-90 Serum creatinine mg/dl 2.5 0.6-1.2 NTP A-90
More informationPediatrics Grand Rounds 6 September University of Texas Health Science Center at San Antonio, Texas
University of Health Nutritional Management of Children with Chronic Kidney Disease Lori Grant, M.Ed, RD, LD Clinical Instructor Pediatric Nephrology The University of Health Science Center San Antonio
More informationFuture Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008
Future Direction of Anemia Management in ESRD Jay B. Wish, MD 2008 Nephrology Update March 20, 2008 The Evidence Normal Hct Study and CHOIR demonstrate adverse outcomes in ESA patients with target Hgb
More informationCKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow
CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow CKD - KDIGO Definition and Classification of CKD CKD: abnormalities of kidney structure/function for > 3 months with health implications 1 marker
More informationMorbidity & Mortality from Chronic Kidney Disease
Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report
More informationSAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1
Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition
More informationFigure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).
Chronic Kidney Disease (CKD): The New Silent Killer Nelson Kopyt D.O. Chief of Nephrology, LVH Valley Kidney Specialists For the past several decades, the health care needs of Americans have shifted from
More informationDiseases of the Renal System
Diseases of the Renal System Chapter 20 1 2 Kidneys - Anatomy Regulatory and metabolic functions Nephron - functional unit; approx. 1.2 million in each kidney Glomerulus within Bowman s capsule Afferent
More informationpatients and 66% of peritoneal dialysis patients had a systolic blood pressure within the 90th percentile
Renal Registry 5th Annual Report: Chapter 7 Clinical, Haematological and Biochemical Parameters in Patients receiving Renal Replacement Therapy in Paediatric s in the in 2: national and centre-specific
More informationCKDinform: A PCP s Guide to CKD Detection and Delaying Progression
CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the
More information